Geoffrey Clifton-Brown – 2015 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Geoffrey Clifton-Brown on 2015-10-14.
To ask the Secretary of State for Health, when he plans next to publish a report on international comparisons of medicines usage; at what frequency he will publish such reports; what assessment he has made of the implications for his policies of the most recently published report; and if he will make a statement.
George Freeman
International comparisons of medicines usage are included in the annual publication of the life science competitiveness indicators. This report is published annually, it was last published in March 2015, and the next publication will be inMarch 2016. This provides comparisons of the usage of innovative National Institute for Health and Care Excellence approved medicines per head of the population, over time. It does not make adjustments for the prices of medicines and the level of expenditure on medicines in different countries or the financial sustainability of different levels of uptake.
The Accelerated Access Review (AAR) is looking at ways to revolutionise the speed at which 21st century innovations in medicines, medical technologies and digital products get to National Health Service patients and their families. As part of the AAR, RAND Europe completed a piece of work to explore learning from international comparators on how to accelerate access to innovative drugs and medical technologies. This informed much of our early stakeholder engagement and scoping work. The AAR has commissioned a further piece of research to look at best practice international funding and reimbursement models, including testing how these could be applicable to this country’s health and care system.
Link to competitiveness indicators March 2015 publication:
https://www.gov.uk/government/publications/life-science-sector-data
RAND Europe – Improving Access to Medical Technologies – An International Review:
“
